The Blue Harbinger Weekly — Blue Harbinger Investment Research

New Options Trade: Very High Upfront Income, Bullish Vertical Put Spread

This report reviews an attractive high-income-generating options trade on a compelling long-term fintech business (Warren Buffett and Cathie Wood are both shareholders). The trade generates attractive upfront premium income, and gives you a shot at picking up shares of this attractive business at a lower price. We believe the trade is an attractive one to place today, and potentially over the next few trading sessions, as long as the price of the underlying shares doesn’t move too dramatically.

Share

Celsius Fitness Drinks: High-Growth Disruptor, Important Things to Consider

Celsius Holdings offers fitness-focused energy drinks, and the business has been experiencing dramatic growth as the pandemic serendipitously led the company to shift its marketing strategy from gyms to mainstream. Investors are optimistic as the company has serious momentum but currently holds just over 1% market share (suggesting a lot of room for continuing growth). However, Celsius faces formidable competition (such as Red Bull, Monster and Rockstar). In this report, we consider the business model, market opportunity, financials, valuation and risks, and then conclude with our opinion on investing.

Share

Dry Bulk Shipper: 6.4% Yield, Attractive Supply-Demand Dynamic

There is a lot to like about this large dry bulk shipper, not the least of which is its attractive 6.4% dividend yield. More specifically, the company is benefiting from a cyclical rebound in dry bulk shipping rates, on both the supply and demand sides. It’s expected to announce earnings on August 5th, and its 8.0% yield baby bonds are expected to be called at the end of this month. In this report, we review the business, market conditions, prospects, valuation and risks, and then conclude with our opinion on investing.

Share

New Options Trade: Dividend Capture Covered Calls, Blue Chip Pharma

Today we share an income-generating options trade on a healthy-dividend blue-chip pharmaceuticals company. The trade not only generates compelling premium income and gives you a shot at selling the shares at a solid gain in less than 1-month, but it also gives you a chance to capture the dividend payment if the shares don’t get called away from you before the ex-dividend date in a little over 1-week from today. Also very important, we like this healthy-dividend company as a long-term investment, and we wouldn’t mind holding on to the shares if they don’t get called away. This is an attractive trade to place today and potentially over the next few trading sessions.

Share

Powerful Blue Chip: Highly Attractive, Classically Misunderstood

The stock we review in this report is highly attractive, even though its financials are misunderstood by many. Specifically, the company is the strong leader in providing a business critical function that is being transformed from an outdated manual process into a 21st century digitized cloud-based solution. And the total addressable market opportunity (to keep growing rapidly) is massive and growing. Unfortunately, many investors misunderstand the high valuation multiples and low profitability as a weakness. To the contrary, it’s an absolute strength and the right thing to do as the company capitalizes on the highly attractive opportunity. This business will eventually become a massive cash cow.

Share

Top 5 Growth Stocks: Despite Fear, Massive Upside

One of the biggest deterrents to successful long-term growth investing is near-term fear. Whether its driven by the relentless media fearmongering, short-term Wall Street valuation methodologies, or the psychological notion that people react more than twice as strong to down moves as up moves, near-term fear prevents investors from participating in massive long-term gains. It’s challenging for some people to recognize the amazing power of compound growth, but it is often referred to as the 8th wonder of the world by those who understand it. In this report, we countdown our top 10 growth stocks with massive upside potential (despite near-term fear), starting with #10 and finishing with our #1 top idea.

Share

New Options Trade: High Upfront Income, Attractive Mortgage REIT

As interest rates (including mortgage rates) have slipped in recent weeks, so too has the share price of this attractive mortgage REIT fallen. It now trades at a significant discount to its last reported book value, and we believe this combination of events has set us up for a nice high-income-generating options trade. Specifically, we believe the trade described in this report is an attractive one to place today and potentially over the next few trading sessions, as long as the underlying share price doesn’t move too dramatically before then.

Share

New Options Trade: Dividend Capture Covered Calls, Energy Midstream

Today’s income-generating options trade utilizes a dividend capture covered call strategy, whereby the trades nets you attractive premium income, potentially attractive dividend income (if the shares don’t get called), and captures attractive share price gains (if the shares do get called). The trade is on a compelling “high-dividend” midstream company that we own already, but you can also purchase the shares as part of this trade if you don’t own them already. We believe the trade is attractive to place today, and potentially over the next few days, as long as the share price doesn’t move too dramatically, and as long as you own the shares (settled in your account) prior to the ex-dividend date (expected on or around July 29th).

Share

The Trade Desk: Growth at an (Un) Reasonable Price?

If you don’t know, The Trade Desk (TTD) is growing rapidly. The company’s self-service software platform (that enables ad agencies and brands to make data-driven ad placements across a variety of mediums) is benefiting dramatically from secular growth in digital ads and Connected TVs. Further, the company’s recent launch of a more secure and effective Unified 2.0 solution (an alternative to cookies) has added to the growth momentum. But is the company’s valuation simply too high? In this report, we review The Trade Desk’s business model, its market opportunity, financials, valuation and risks, and then conclude with our opinion on whether the shares offer an attractive balance between risks and rewards.

Share

Digital Payments Company: Attractive Growth and Value

The company we review in this report has tremendous long-term price appreciation potential—thanks to its ongoing high growth trajectory, its large total addressable market and its reasonable valuation. The pandemic accelerated one half of its business, and now the other half is expected to accelerate thanks to re-openings. This one doesn’t pay a dividend, and the growth can be lumpy, but over the long term the company has a clear path to dramatic share price gains. In this report, we review the health of the business, growth opportunities, valuation, risks, and conclude with our opinion on investing.

Share

New Purchase: High Growth Media Platform Stock

This is simply a quick note to let you know we made a new purchase in our Discipline Growth portfolio this morning. This is a high growth company that recently posted another quarter of impressive results whereby they raised forward guidance on their already very strong and healthy growing business. The shares are trading below the price when we released our original full write-up on the company back in March (see that full write-up below). And as mentioned, the business continues to improve. The shares sold off hard on Friday (on what appears to be incorrect news about an application rule change). We don’t expect the price to stay low for long, and we just added shares this morning.

Share

Very High-Income Options Trade, Bullish Vertical Put Spread

This global oncology company with patented “Tumor Treating Fields” (“TTF”) technology. It has multiple programs in phase 2 and phase 3 of clinical trials which can potentially result in exponential revenue growth and Total Addressable Market (“TAM”) expansion. The shares are volatile (for example yesterday they declined more than 14% as the market reacted to the company’s final results from a liver cancer study), and this volatility has given rise to an attractive high-income-generating options trade. The trade strategy sounds complex (i.e. “bullish vertical put spread”), but it’s not. It puts attractive upfront premium in your pocket today, it gives you a chance to pick up shares of this attractive stock at a lower price, and it gives you a little insurance on the downside (i.e. your max loss is limited). We believe this is an attractive trade to place today—and potentially over the next few trading sessions (including post the holiday)—as long as the underlying share price doesn’t move too dramatically before then.

Share